Society for Vascular Medicine
2012 Call for Abstracts Program

Timeline
Online Abstract Submissions Open October 4, 2011
Abstract Submission Deadline January 18, 2012
Finalists notified February 29, 2012
Poster presentations and finalists' oral presentations June 14, 2012

Submission Requirements

  • Only online submissions are accepted.
  • There is no fee for submitting an abstract.
  • Work covered by the abstract must not have been published (manuscript or abstract) prior to June 14, 2012.
  • If the abstract has been presented or accepted for presentation at another national meeting or world congress, it should not be submitted to SVM
  • Submission of an abstract constitutes a commitment by the author(s) to present a poster if accepted. Failure to present and register for the meeting, if not justified, will jeopardize future acceptance of abstracts. If an emergency arises and the presenter is unable to attend, he/she must notify SVM headquarters in writing prior to the meeting that he/she is withdrawing the abstract or naming a substitute presenter. All notices should be emailed to info@vascularmed.org. The substitute must be a co-author and preferably not already presenting another abstract. Failure to follow these procedures may result in the submitter being prohibited from presenting at the next SVM meeting.
  • There is no limit to the number of abstracts an investigator may submit; however, investigators should not submit the same research. Abstracts that appear to be replicate versions of a single study will be rejected.
  • Investigators need not be SVM members to participate.
  • Submitted abstracts will be peer reviewed.
  • Abstracts selected for presentation will be scheduled in a poster session in Minneapolis, MN on June 14, 2012.
  • If the abstract is accepted, the presenter will be asked to disclose any financial interest/arrangement or affiliation with any commercial organizations that could be perceived as a real or apparent conflict of interest in the context of their presentation subject matter. Commercial relationships that occurred within the 12 months prior to the date of the meeting (June 3, 2011 - June 14, 2012) must be disclosed. These are typically relationships such as grants, speakers' bureau, major stockholder or other company ownership, etc. Funding from government and nonprofit sources does not need to be disclosed. Disclosure information will be published in the final program.
  • Accepted posters abstracts are also submitted to the Vascular Medicine Editorial Office for printing in the annual meeting issue of Vascular Medicine.

Categories:
Each abstract must identify the category and topic that best fits the content. The program committee reserves the right to change the category if appropriate.

In which category do you wish to be considered?

  • Basic Science
  • Clinical Science/Epidemiology

What topic/topics best describe your research?

  • Angiogenesis/Vasculogenesis
  • Arterial and Aortic Disease
  • Cerebrovascular Disease and Stroke
  • Endothelial Function and Surrogate Markers
  • Exercise Physiology
  • Free Radicals, Ischemia and Hypoxia
  • Gene Regulation, Genetics, and Genomics and Proteomics
  • Hypertension and Vasoactive Molecules
  • Imaging
  • Inflammation and Connective Tissue Disorders
  • Lymphology and Lymphatic Disease
  • Metabolism and Endocrine
  • Other
  • Stem Cells/Tissue Engineering/Regenerative Medicine
  • Thrombosis and Hemostasis
  • Vascular Cell Biology and Signaling
  • Venous Disease
  • Vascular Surgery

Abstract Title:

  • Capitalize all words that should be capitalized and do not use non-standard abbreviations. Commercial names may not be used. Limit titles to 250 characters.

Abstract Text, Tables and Images:

  • Abstracts are limited to 1,750 characters (including spaces).
  • Abstracts should describe clinical research in vascular medicine or basic research in vascular biology.
  • Do not repeat or include title, author(s) or author affiliation(s).
  • Standard abbreviations may be used without definition. Nonstandard abbreviations must be placed in parenthesis after the first use.
  • Before inserting text, run spell check since it isn't possible to spell check from within the abstract submission system.
  • Do not include references, credits or grant support.
  • Text should include a brief description of background, methods, results and conclusion(s).
  • Only one (1) table or graph/image is permitted.

Selection Criteria
Submissions are scored by the committee on a scale of 1 to 5 as follows:

1 = Outstanding
2 = Superior
3 = Good
4 = Fair
5 = Poor


Young Investigator Award

In honor of Jay D. Coffman (1928-2006), distinguished internist and researcher of vascular medicine and clinical cardiology, SVM sponsors an annual award in vascular medicine research. Learn more.

Updated January 19, 2012